Clinical Trial Update: GLP-1 Receptor Agonist for Reduction of Myocardial Injury After Non-cardiac Surgery [Phase 4]

View source ↗

Summary

Phase 4 clinical trial sponsored by The University of Hong Kong is evaluating whether a GLP-1 receptor agonist can reduce myocardial injury after non-cardiac su…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Injury

Drugs mentioned

• GLP-1 receptor agonist (unspecified)

Snippet

Sponsor: The University of Hong Kong | Conditions: Myocardial Injury | Phase 4 | Status: RECRUITING